Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

Overview of attention for article published in Journal of Clinical Oncology, October 2013

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 14 news outlets
blogs: 3 blogs
policy: 3 policy sources
twitter: 29 X users

patent: 25 patents
facebook: 2 Facebook pages
wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 3318 Dimensions

Readers on

mendeley: 509 Mendeley

Summary News Blogs Policy documents X Patents Facebook Wikipedia Dimensions citations

So far, Altmetric has seen 3 posts from 3 blogs.

ONLINE FIRST: HER2 Guideline Won’t Deter Genomic Testing

Voices: Posts, 02 Dec 2013

By Massimo Cristofanilli…

ASCO recommends all breast cancer patients receive HER2 testing

Grey Horizon, 18 Oct 2013

Guidelines on HER2 testing in patients with invasive breast cancer by the American Society of Clinical Oncology (ASCO) and the…

Updated Breast Cancer Guidelines for HER2 Testing

Physician's Weekly, 16 Oct 2013

A new update to clinical practice guidelines for HER2 testing in breast cancer was published online last week by the American…